Product NDC: | 55289-872 |
Proprietary Name: | SEROQUEL |
Non Proprietary Name: | Quetiapine fumarate |
Active Ingredient(s): | 25 mg/1 & nbsp; Quetiapine fumarate |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 55289-872 |
Labeler Name: | PD-Rx Pharmaceuticals, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020639 |
Marketing Category: | NDA |
Start Marketing Date: | 20110719 |
Package NDC: | 55289-872-30 |
Package Description: | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (55289-872-30) |
NDC Code | 55289-872-30 |
Proprietary Name | SEROQUEL |
Package Description | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (55289-872-30) |
Product NDC | 55289-872 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Quetiapine fumarate |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 20110719 |
Marketing Category Name | NDA |
Labeler Name | PD-Rx Pharmaceuticals, Inc. |
Substance Name | QUETIAPINE FUMARATE |
Strength Number | 25 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Atypical Antipsychotic [EPC] |